Executive Leadership

Nikhil Nayak
Chief Operating Officer


Years of Experience: 21+
Specialties: Healthcare, Global Marketing, Product Launch & Strategy, Business Development
Achievements: Washington University, B.A. Biology; NYU Stern School of Business, MBA Finance and Marketing, International Business; 2003 MM&M Marketing Team of the Year
Publications: “Marketing: Success Beyond the Silos



Nikhil was appointed Chief Operating Officer in August 2019, promoted after proudly serving as Chief Commercial Officer at Confirm BioSciences since September 2018. In this role, he is focused on shaping the strategic direction and commercialization of Confirm’s products across all business units. Prior to Confirm, Nikhil was the Chief Marketing Officer at Millennium Health, where he served as a member of the Executive Leadership Team. He led corporate strategy, product development, marketing, and corporate communications functions, reporting directly to the Chairman of the Board and CEO. After a successful crisis management and restructure in 2015, Nikhil created a strategic and cohesive product development and commercialization process at Millennium that delivered several successful product launches and profitable growth.



Nikhil Nayak has over two decades of relevant healthcare experience in all aspects of global commercialization, including corporate strategy, life cycle product management, business development, global marketing & sales, finance & digital strategies.

Over the course of his career at Forest Laboratories Inc. (now Allergan), Nikhil held a variety of positions of increasing responsibility in sales, marketing, and business development. In his final role at Forest, Nikhil served as Executive Director of Global Marketing & Commercialization, where he steered the successful approvals and launches of several products in Canada, Europe, and Latin America. He was the head of the Namenda franchise, accelerating growth to “Blockbuster Status” for this Alzheimer’s drug while overseeing future development programs. He was also instrumental in the successful launches of Bystolic, and blockbuster antidepressants Celexa and Lexapro, for which he was recognized as part of Medical Marketing & Media’s 2003 “Brand Team of the Year“.

Nikhil received his Bachelor’s degree in Biology from Washington University in St. Louis, and his Master’s in Business Administration from New York University, Stern School of Business.